Global Vasomotor Symptoms of Menopause Treatment Market Research Report 2024

Report ID: 1977369 | Published Date: Feb 2026 | No. of Page: 88 | Base Year: 2025 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Estetrol
        1.2.3 Fezolinetant
        1.2.4 FP-101
        1.2.5 HBN-2
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Vasomotor Symptoms of Menopause Treatment Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Homecare
        1.3.4 Clinic
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Vasomotor Symptoms of Menopause Treatment Market Perspective (2018-2029)
    2.2 Vasomotor Symptoms of Menopause Treatment Growth Trends by Region
        2.2.1 Global Vasomotor Symptoms of Menopause Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Vasomotor Symptoms of Menopause Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Vasomotor Symptoms of Menopause Treatment Market Dynamics
        2.3.1 Vasomotor Symptoms of Menopause Treatment Industry Trends
        2.3.2 Vasomotor Symptoms of Menopause Treatment Market Drivers
        2.3.3 Vasomotor Symptoms of Menopause Treatment Market Challenges
        2.3.4 Vasomotor Symptoms of Menopause Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue
        3.1.1 Global Top Vasomotor Symptoms of Menopause Treatment Players by Revenue (2018-2023)
        3.1.2 Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Vasomotor Symptoms of Menopause Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Vasomotor Symptoms of Menopause Treatment Revenue
    3.4 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio
        3.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Vasomotor Symptoms of Menopause Treatment Revenue in 2022
    3.5 Vasomotor Symptoms of Menopause Treatment Key Players Head office and Area Served
    3.6 Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
    3.7 Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Vasomotor Symptoms of Menopause Treatment Breakdown Data by Type
    4.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2024-2029)
5 Vasomotor Symptoms of Menopause Treatment Breakdown Data by Application
    5.1 Global Vasomotor Symptoms of Menopause Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Vasomotor Symptoms of Menopause Treatment Market Size (2018-2029)
    6.2 North America Vasomotor Symptoms of Menopause Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2018-2023)
    6.4 North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Vasomotor Symptoms of Menopause Treatment Market Size (2018-2029)
    7.2 Europe Vasomotor Symptoms of Menopause Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2018-2023)
    7.4 Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size (2018-2029)
    8.2 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2018-2023)
    8.4 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Vasomotor Symptoms of Menopause Treatment Market Size (2018-2029)
    9.2 Latin America Vasomotor Symptoms of Menopause Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2018-2023)
    9.4 Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size (2018-2029)
    10.2 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2018-2023)
    10.4 Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Amgen Inc.
        11.1.1 Amgen Inc. Company Detail
        11.1.2 Amgen Inc. Business Overview
        11.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Introduction
        11.1.4 Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.1.5 Amgen Inc. Recent Development
    11.2 EndoCeutics, Inc.
        11.2.1 EndoCeutics, Inc. Company Detail
        11.2.2 EndoCeutics, Inc. Business Overview
        11.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
        11.2.4 EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.2.5 EndoCeutics, Inc. Recent Development
    11.3 Euroscreen S.A.
        11.3.1 Euroscreen S.A. Company Detail
        11.3.2 Euroscreen S.A. Business Overview
        11.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Introduction
        11.3.4 Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.3.5 Euroscreen S.A. Recent Development
    11.4 MenoGeniX, Inc.
        11.4.1 MenoGeniX, Inc. Company Detail
        11.4.2 MenoGeniX, Inc. Business Overview
        11.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
        11.4.4 MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.4.5 MenoGeniX, Inc. Recent Development
    11.5 Mithra Pharmaceuticals S.A.
        11.5.1 Mithra Pharmaceuticals S.A. Company Detail
        11.5.2 Mithra Pharmaceuticals S.A. Business Overview
        11.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Introduction
        11.5.4 Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.5.5 Mithra Pharmaceuticals S.A. Recent Development
    11.6 Pherin Pharmaceuticals, Inc.
        11.6.1 Pherin Pharmaceuticals, Inc. Company Detail
        11.6.2 Pherin Pharmaceuticals, Inc. Business Overview
        11.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
        11.6.4 Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.6.5 Pherin Pharmaceuticals, Inc. Recent Development
    11.7 Pivot Pharmaceuticals Inc
        11.7.1 Pivot Pharmaceuticals Inc Company Detail
        11.7.2 Pivot Pharmaceuticals Inc Business Overview
        11.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Introduction
        11.7.4 Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.7.5 Pivot Pharmaceuticals Inc Recent Development
    11.8 Radius Health, Inc.
        11.8.1 Radius Health, Inc. Company Detail
        11.8.2 Radius Health, Inc. Business Overview
        11.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
        11.8.4 Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.8.5 Radius Health, Inc. Recent Development
    11.9 TherapeuticsMD, Inc.
        11.9.1 TherapeuticsMD, Inc. Company Detail
        11.9.2 TherapeuticsMD, Inc. Business Overview
        11.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Introduction
        11.9.4 TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
        11.9.5 TherapeuticsMD, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Estetrol
    Table 3. Key Players of Fezolinetant
    Table 4. Key Players of FP-101
    Table 5. Key Players of HBN-2
    Table 6. Key Players of Others
    Table 7. Global Vasomotor Symptoms of Menopause Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Vasomotor Symptoms of Menopause Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Vasomotor Symptoms of Menopause Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Vasomotor Symptoms of Menopause Treatment Market Share by Region (2018-2023)
    Table 11. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Vasomotor Symptoms of Menopause Treatment Market Share by Region (2024-2029)
    Table 13. Vasomotor Symptoms of Menopause Treatment Market Trends
    Table 14. Vasomotor Symptoms of Menopause Treatment Market Drivers
    Table 15. Vasomotor Symptoms of Menopause Treatment Market Challenges
    Table 16. Vasomotor Symptoms of Menopause Treatment Market Restraints
    Table 17. Global Vasomotor Symptoms of Menopause Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Vasomotor Symptoms of Menopause Treatment Market Share by Players (2018-2023)
    Table 19. Global Top Vasomotor Symptoms of Menopause Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasomotor Symptoms of Menopause Treatment as of 2022)
    Table 20. Ranking of Global Top Vasomotor Symptoms of Menopause Treatment Companies by Revenue (US$ Million) in 2022
    Table 21. Global 5 Largest Players Market Share by Vasomotor Symptoms of Menopause Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Vasomotor Symptoms of Menopause Treatment Product Solution and Service
    Table 24. Date of Enter into Vasomotor Symptoms of Menopause Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Vasomotor Symptoms of Menopause Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2018-2023)
    Table 28. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Type (2024-2029)
    Table 30. Global Vasomotor Symptoms of Menopause Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2018-2023)
    Table 32. Global Vasomotor Symptoms of Menopause Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Application (2024-2029)
    Table 34. North America Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 36. North America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Europe Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 39. Europe Vasomotor Symptoms of Menopause Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 42. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 43. Latin America Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Latin America Vasomotor Symptoms of Menopause Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 47. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 48. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 49. Amgen Inc. Company Detail
    Table 50. Amgen Inc. Business Overview
    Table 51. Amgen Inc. Vasomotor Symptoms of Menopause Treatment Product
    Table 52. Amgen Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 53. Amgen Inc. Recent Development
    Table 54. EndoCeutics, Inc. Company Detail
    Table 55. EndoCeutics, Inc. Business Overview
    Table 56. EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Product
    Table 57. EndoCeutics, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 58. EndoCeutics, Inc. Recent Development
    Table 59. Euroscreen S.A. Company Detail
    Table 60. Euroscreen S.A. Business Overview
    Table 61. Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Product
    Table 62. Euroscreen S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 63. Euroscreen S.A. Recent Development
    Table 64. MenoGeniX, Inc. Company Detail
    Table 65. MenoGeniX, Inc. Business Overview
    Table 66. MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Product
    Table 67. MenoGeniX, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 68. MenoGeniX, Inc. Recent Development
    Table 69. Mithra Pharmaceuticals S.A. Company Detail
    Table 70. Mithra Pharmaceuticals S.A. Business Overview
    Table 71. Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Product
    Table 72. Mithra Pharmaceuticals S.A. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 73. Mithra Pharmaceuticals S.A. Recent Development
    Table 74. Pherin Pharmaceuticals, Inc. Company Detail
    Table 75. Pherin Pharmaceuticals, Inc. Business Overview
    Table 76. Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Product
    Table 77. Pherin Pharmaceuticals, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 78. Pherin Pharmaceuticals, Inc. Recent Development
    Table 79. Pivot Pharmaceuticals Inc Company Detail
    Table 80. Pivot Pharmaceuticals Inc Business Overview
    Table 81. Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Product
    Table 82. Pivot Pharmaceuticals Inc Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 83. Pivot Pharmaceuticals Inc Recent Development
    Table 84. Radius Health, Inc. Company Detail
    Table 85. Radius Health, Inc. Business Overview
    Table 86. Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Product
    Table 87. Radius Health, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 88. Radius Health, Inc. Recent Development
    Table 89. TherapeuticsMD, Inc. Company Detail
    Table 90. TherapeuticsMD, Inc. Business Overview
    Table 91. TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Product
    Table 92. TherapeuticsMD, Inc. Revenue in Vasomotor Symptoms of Menopause Treatment Business (2018-2023) & (US$ Million)
    Table 93. TherapeuticsMD, Inc. Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Vasomotor Symptoms of Menopause Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Vasomotor Symptoms of Menopause Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Estetrol Features
    Figure 4. Fezolinetant Features
    Figure 5. FP-101 Features
    Figure 6. HBN-2 Features
    Figure 7. Others Features
    Figure 8. Global Vasomotor Symptoms of Menopause Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Vasomotor Symptoms of Menopause Treatment Market Share by Application: 2022 VS 2029
    Figure 10. Hospital Case Studies
    Figure 11. Homecare Case Studies
    Figure 12. Clinic Case Studies
    Figure 13. Vasomotor Symptoms of Menopause Treatment Report Years Considered
    Figure 14. Global Vasomotor Symptoms of Menopause Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Vasomotor Symptoms of Menopause Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Vasomotor Symptoms of Menopause Treatment Market Share by Region: 2022 VS 2029
    Figure 17. Global Vasomotor Symptoms of Menopause Treatment Market Share by Players in 2022
    Figure 18. Global Top Vasomotor Symptoms of Menopause Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasomotor Symptoms of Menopause Treatment as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Vasomotor Symptoms of Menopause Treatment Revenue in 2022
    Figure 20. North America Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Vasomotor Symptoms of Menopause Treatment Market Share by Country (2018-2029)
    Figure 22. United States Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Vasomotor Symptoms of Menopause Treatment Market Share by Country (2018-2029)
    Figure 26. Germany Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Share by Region (2018-2029)
    Figure 34. China Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Vasomotor Symptoms of Menopause Treatment Market Share by Country (2018-2029)
    Figure 42. Mexico Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Share by Country (2018-2029)
    Figure 46. Turkey Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Vasomotor Symptoms of Menopause Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Amgen Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 49. EndoCeutics, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 50. Euroscreen S.A. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 51. MenoGeniX, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 52. Mithra Pharmaceuticals S.A. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 53. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 54. Pivot Pharmaceuticals Inc Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 55. Radius Health, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 56. TherapeuticsMD, Inc. Revenue Growth Rate in Vasomotor Symptoms of Menopause Treatment Business (2018-2023)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen Inc.
EndoCeutics, Inc.
Euroscreen S.A.
MenoGeniX, Inc.
Mithra Pharmaceuticals S.A.
Pherin Pharmaceuticals, Inc.
Pivot Pharmaceuticals Inc
Radius Health, Inc.
TherapeuticsMD, Inc.
Frequently Asked Questions
Vasomotor Symptoms of Menopause Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Vasomotor Symptoms of Menopause Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Vasomotor Symptoms of Menopause Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sicca Syndrome Drug

This report aims to provide a comprehensive presentation of the global market for Sicca Syndrome  ... Read More